FDA official logo
GSRS logo
PFDA official logo

TADOCIZUMAB

  • UNII: R34T642CGV
  • Preferred Substance Name: TADOCIZUMAB

  • 339086-80-5
  • C4G1
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN INTEGRIN .ALPHA.IIB.BETA.3) FAB FRAGMENT (HUMAN-MOUSE MONOCLONAL C4G1 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL C4G1 .KAPPA.-CHAIN
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN INTEGRIN .ALPHA.IIB.BETA.3) FAB FRAGMENT (HUMAN-MOUSE MONOCLONAL C4G1 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL C4G1 .KAPPA.-CHAIN
  • TADOCIZUMAB [INN]
  • TADOCIZUMAB [USAN]
  • YM337
  • YM-337

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.